Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Literature
1.
Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S et al (2004) Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 44(12):1774–1789PubMedCrossRef
2.
3.
4.
5.
Wiersum-Osselton JC, Whitaker B, Grey S, Land K, Perez G, Rajbhandary S, Andrzejewski C Jr, Bolton-Maggs P, Lucero H, Renaudier P, Robillard P, Santos M, Schipperus M (2019) Revised international surveillance case definition of transfusion-associated circulatory overload: a classification agreement validation study. Lancet Haematol 6(7):e350–e358. https://​doi.​org/​10.​1016/​S2352-3026(19)30080-8 PubMedCrossRef
Metadata
Title
An Update of the Transfusion-Related Acute Lung Injury (TRALI): A Proposed Modified Definition and Classification Scheme Definition
Authors
Alexander P. J. Vlaar
Steve Kleinman
Publication date
01-07-2020
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2020
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-019-01175-w

Other articles of this Issue 3/2020

Indian Journal of Hematology and Blood Transfusion 3/2020 Go to the issue

Short Communication

Peripheral Blood and Bone Marrow Findings in Chronic Alcoholics with Special Reference to Acquired Sideroblastic Anemia

Correspondence

Factors Determining Inferior Survival Outcomes After Autologous Stem Cell Transplantation in Multiple Myeloma at a Referral Center in a Developing Country

Correspondence

Accelerated Intravascular Activation of Coagulation During Cardiopulmonary Bypass

Correspondence

Spontaneus Triplet Birth After Acute Lymphoblastic Leukemia Treatment

Original Article

Magnesium Therapy Improves Rotational Thromboelastometry Findings Prior to Liver Transplantation: A Randomized Clinical Trial

Original Article

MicroRNA 30a Mediated Autophagy and Imatinib Response in Egyptian Chronic Myeloid Leukemia Patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits